DOCSLIB.ORG

Inhibition of Mammalian DNA Polymerase by the 5'-Triphosphate of 9-Jo-D-Arabinofuranosyladenine1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Inhibition of Mammalian DNA Polymerase by the 5'-Triphosphate of 9-Jo-D-Arabinofuranosyladenine1 [CANCER RESEARCH 27, 1528-1533, September 1967] Inhibition of Mammalian DNA Polymerase by the 5'-Triphosphate of 9-jo-D-Arabinofuranosyladenine1 J. J. FORTH-' AND SEYMOUR S. COHEN Department of Pathology and the Department of Therapeutic Research, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania 19104 SUMMARY polymerization by polynucleotide phosphorylase of E. coli of The 5'-triphosphate of 9-0-D-arabinoturanosyladenine (ara- ADP and CDP to polyadenylate and polycytidylate, respectively, were sharply inhibited by ara-CDP (2) and by ara-ADP (12), ATP) was tested as a substrate or inhibitor of polynucleotide reactions leading to polymerization by this enzyme are not synthesis using bacterial and mammalian polymerases. The thought to be physiologically significant (2, 12). compound was inactive as a substrate for mammalian DXA In contrast to the results with E. coli DNA polymerase, York polymerase, bacterial DNA polymerase, mammalian RNA and LePage (18) recently reported that mammalian DNA poly polymerase, and bacterial RXA polymerase. The compound was merase (from TA 3 ascites cells) was noncompetitively inhibited found to inhibit DNA synthesis catalyzed by DNA polymerase by ara-ATP. This report prompted us to reexamine the effect of obtained from both calf thymus and bovine lymphosarcoma; the ara-ATP on the DNA-dependent polymerases. We have con results suggest a form of mixed inhibition between ara-ATP and firmed the finding of York and LePage that the mammalian deoxyadenosine triphosphate. No significant inhibition of Esch- enzyme is inhibited by ara-ATP; however, the inhibition appears erifhia coli DNA polymerase was observed, and RNA poly to be partially competitive with deoxy-ATP. We have also merases of both bacteria and mammalian cells were not inhibited shown that the E. coli enzyme is relatively insensitive to this by ara-ATP. In general, ribonucleoside triphosphates did not compound. inhibit DNA polymerase and deoxyribonucleoside triphosphates did not inhibit RNA polymerase. MATERIALS AND METHODS INTRODUCTION Preparation of ara-ATP. ara-A was synthesized by the D-Arabinosyl nucleosides inhibit the growth of both cultured method of Glaudemans and Fletcher (10). A portion was tritiated mammalian cells and bacteria, as well as the multiplication of by the Wilzbach procedure (17), by New England Nuclear Corp., DNA viruses in animal cells [see review by Cohen (4)]. While combined with 10 parts of nonradioactive ara-A and recrystal- the effect appeared to be primarily due to inhibition of DNA lized to constant specific activity. 5'-ara-AMP was prepared by synthesis in intact cells (3, 4, 15), earlier studies in this laboratory the Tener procedure (16). (The insolubility of ara-A required with nucleotides and enzymes of Escherichia coli catalyzing the addition of dimethyl formamide to assist in solubilizing the polynucleotide synthesis failed to elicit possible enzymatic sites nucleoside prior to the addition of the reagents.) The 5'-ara-AMP of inhibition. For example, Cardeilhac and Cohen (2) found that was separated on Dowex 1-C1 from unreacted ara-A, a cyclic bacterial DNA polymerase was not significantly inhibited by ara-AMP, and ara-A-polyphosphates. 5'-ara-AMP was eluted ara-CTP.3 Neither was RNA polymerase, and, although the in 33','r yield by 5 HIMHC1 followed by a cyclic ara-AMP in 11% yield. [Although the N to P ratio, Chromatographie prop erties, and ease of formation of the cyclic nucleotide suggested 1This investigation was supported by USPHS Grants 7005from that it might be 3',5'-cyclic ara-AMP, it was stable to heating the National Institute of Allergy and Infectious Disease and 10390 in Ha(OH)2 and may actually be the rt's-2',5'-cyclic ara-AMP from the National Institute of (¡eneralMedical Sciences. 2Research Career Development Awardee (GM-KS-12,888) of (see Ref. 4, p. 33)]. The 5'-ara AMP was isolated as the barium salt, converted to the USPIIS. 3The abbreviations used are: ara-A or arabinosyl adenine, the free acid with Dowex-50-H+, and dried in vacuo. The crystal 9-0-D-arabiiiofuraiiosyladeniiie; ara-AMP, ara-ADP, ara-ATP, line acid was dissolved in methanol and trioctylamine. The 9-0-D-aral)inofuranosyladenine-5'-mono-, di-, and -triphosphates; methanol was removed and dioxane and dimethylformamide ara-COP, ara-CTP, l-/3-D-arabinofuranosylcytosine-5'-di- and were used to dry the trioctylamine salt of ara-AMP. The latter triphosphates; UNA polymerase, nucleoside triphosphate: RNA was converted to the P'-ara-A-5'-P2-diphenylpyrophosphate by nucleotidyltransferase, EC 2.7.7.6; DNA polymerase, deoxy- the procedure of Michelson (13). The trioctylamine salt was dis nucleoside triphosphate: DNA deoxynucleotidyl transferase, EC 2.7.7.7. ; TTP, deoxythymidine-5'-triphosphate; deoxy-ATP, solved in 0.4 ml dimethylformamide plus 1.5 ml dioxane, and to deoxyadenosine-5'-triphosphate; ADP, adenosine-5'-diphosphate; this solution 0.2 ml dry tributylamine and 0.12 ml dry redistilled CDP, cytidine-5'-diphosphate; deoxy-GMP, deoxyguanosine-5'- diphenylphosphoryl chloride were added. After three hours at phosphate. room temperature, the solvent was removed and the oil caused to Received September 22, 190«;acceptedMay 2, 1967. congeal by the addition of anhydrous ether at 0°C.The ether 1528 CANCER RESEARCH VOL. 27 Downloaded from cancerres.aacrjournals.org on September 29, 2021. © 1967 American Association for Cancer Research. Inhibition of Mammalian DXA Polymerase by ara-ATP ara-ATP 4.8>tM ara-ATP 9.6/iM ara-ATP 19.2/iM ara-ATP 24 32 40 48 56 -0.05 0.05 0.10 0.15 _[_ S 8 16 24 ¡(/¿M) CHART 1.4-C. Inhibition of DNA polymerase of lymphosarcoma by ara-ATP. The reaction mixture (0.25 ml) contained: 50 mM tris- (hydroxymethyl)aminomethene buffer, pH 8.1; 2 mm MgCU ; 2 mM 2-mercaptoethanol; 80 ¿IMeachof dTTP, dCTP, and dGTP-"C (1.05 X IO6 cpm//umole) ; heated salmon DNA, 28.5 mamóles of deoxynucleotide; varying concentrations of dATP and ara-ATP; and 200 fig of enzyme. After incubation for 60 min at 37°C,the reaction was terminated by the addition of 0.2 ml of 7% perchloric acid, albumin (1 mg) was added, and the acidified mixture centrifuged. The precipitate was washed twice with 3-ml portions of 1% perchloric acid, dissolved in 1.5 ml of 0.2 N NH4OH, decanted into metal planchéis,dried, and the radioactivity measured in a Geiger-Müller counter with Micro- mil window. No correction for self-absorption (approximately 25% in all samples) has been made. In Graphs 1/i and 1C, incorporation in the absence of dATP (0.06 mamóle) was subtracted. Similar plots were obtained when incorporation in the absence of I)NA (<0.01 m/imole) was used as the "blank." Charts 1.4 and Iß:• •,no ara-ATP; O O, 1.9 AIMara-ATP; D D, 4.8 AIMara-ATP; V V, 9.6 ¿«Mara-ATP;A A, 19.2 ¿IMara-ATP. Chart 1C: • ».11.2MMdATP; V V, 16.8AIMdATP; O O, 28.0ACMdATP. ara-ATP, 9-/3-D-arabinofuranosyladenine; dATP, dCTP, dGTP, and dTTP, 5'-triphosphates, respectively, of deoxyadenosine, deoxy- cytidine, deoxyguanosine, and deoxythymidine, dGMP, deoxyguanosine-5'-phosphate. SEPTEMBER 1967 1029 Downloaded from cancerres.aacrjournals.org on September 29, 2021. © 1967 American Association for Cancer Research. J. J. Furth and Seymour S. Cohen was decanted and the precipitate rewashed with ether. The TABLE 1 precipitate was redried by the addition and evaporation of Effect of ATP" on DNA Polymerase of Lymphosarconia dioxane and a solution of tributylamine pyrophosphate (750 The reaction mixture was as described in the legend to Chart 1. Amólesin 1 ml) and 0.6 ml dry pyridine were added. The mix The concentration of dATP was 16.8 AIM;the concentration of ATP ture was shaken gently at room temperature for 45 minutes and is specified in the table. After incubation for 30 minutes at 37°C, the pyridine removed in vacuo. The reaction mixture was dis incorporation of radioactive substrate into acid-insoluble form solved in water and applied to a Dowex 1-C1 column. ara-ADP was determined as described in the legend to Chart 1. was eluted, in 6% yield, with a solution containing 10 HIMHC1 („M)ATP09.Concentration and 25 HIMLiCl, and ara-ATP in 25% yield with a solution con acidincorporated(„„moles)168173188192 taining 10 HIMHC1 and 10 mia LiCl. The solution of ara-ATP was neutralized with tributylamine, taken almost to dryness, precipitated with ethanol and acetone (in which LiCl is soluble), washed with acetone, and dried. The G38.476.8dATP16.816.816.816.8Deoxyguanylic product contained 2.95 ¿miólesorganicP per /wnole adenine, assuming ara-ATP to have the extinction coefficient of ATP. The ratio of acid-labile P to total P was 0.69 and the product " ATP, adenosine-5'-triphosphate ; dATP, deoxyadenosine-5'- contained less than 0.05 /umole Pi per mole ara-ATP. The com triphosphate. pound was hydrolyzed completely to ara-A by rattlesnake venom and is therefore considered to be entirely the 5'-phosphate. Preparation of Mammalian Polymerases. Tissue was disrupted in a Waring Blendor and the crude extract centrifuged at 100,000 X g. Protamine sulfate was added to the supernatant solution and the precipitate collected by centrifugation. DNA polymerase was extracted from this pellet with 0.1 M sodium Buccinate, pH 6, and concentrated by precipitation with (NIL.)2- SÃœ4.RNA polymerase was then extracted from the pellet with 0.5 Msodium succinate, pH 6. The preparation and properties of RXA polymerase have been described previously (6). The preparation of DNA polymerase used in these experi ments, unless otherwise specified, was obtained from bovine lymphosarcoma.
Load more

Recommended publications
  • A Guardian of the Development of Diabetic Retinopathy
    Diabetes Volume 67, April 2018 745 Sirt1: A Guardian of the Development of Diabetic Retinopathy Manish Mishra, Arul J. Duraisamy, and Renu A. Kowluru Diabetes 2018;67:745–754 | https://doi.org/10.2337/db17-0996 Diabetic retinopathy is a multifactorial disease, and the molecular mechanism of the development of diabetic reti- exact mechanism of its pathogenesis remains obscure. nopathy remains to be established. Sirtuin 1 (Sirt1), a multifunctional deacetylase, is impli- Sirtuin 1 (Sirt1), a member of the silent information cated in the regulation of many cellular functions and in regulator 2 family, is a class III histone deacetylase that gene transcription, and retinal Sirt1 is inhibited in di- interacts with target proteins and regulates many cellular abetes. Our aim was to determine the role of Sirt1 in the functions including cell proliferation, apoptosis, and inflam- development of diabetic retinopathy and to elucidate the matory responses (6–8). Sirt1 is mainly a nuclear protein, Sirt1 molecular mechanism of its downregulation. Using - and its activity depends on cellular NAD availability (9). It is overexpressing mice that were diabetic for 8 months, Sirt1 expressed throughout the retina, and upregulation of COMPLICATIONS structural, functional, and metabolic abnormalities were protects against various ocular diseases including retinal investigated in vascular and neuronal retina. The role of degeneration, cataract, and optic neuritis (10). Our previous epigenetics in Sirt1 transcriptional suppression was inves- work has shown that Sirt1 expression and activity are de- tigated in retinal microvessels. Compared with diabetic wild-type mice, retinal vasculature from diabetic Sirt1 mice creased in the retina and its capillary cells in diabetes (11).
    [Show full text]
  • Cytosine-Rich
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 12116-12121, October 1996 Chemistry Inter-strand C-H 0 hydrogen bonds stabilizing four-stranded intercalated molecules: Stereoelectronic effects of 04' in cytosine-rich DNA (base-ribose stacking/sugar pucker/x-ray crystallography) IMRE BERGERt, MARTIN EGLIt, AND ALEXANDER RICHt tDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; and tDepartment of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, IL 60611-3008 Contributed by Alexander Rich, August 19, 1996 ABSTRACT DNA fragments with stretches of cytosine matic cytosine ring systems from intercalated duplexes (Fig. 1A). residues can fold into four-stranded structures in which two Second, unusually close intermolecular contacts between sugar- parallel duplexes, held together by hemiprotonated phosphate backbones in the narrow grooves are observed, with cytosine-cytosine+ (C C+) base pairs, intercalate into each inter-strand phosphorus-phosphorus distances as close as 5.9 A other with opposite polarity. The structural details of this (5), presumably resulting in unfavorable electrostatic repulsion if intercalated DNA quadruplex have been assessed by solution not shielded by cations or bridging water molecules. NMR and single crystal x-ray diffraction studies of cytosine- The close contacts between pairs of antiparallel sugar- rich sequences, including those present in metazoan telo- phosphate backbones from the two interdigitated duplexes are meres. A conserved feature of these structures is the absence a unique characteristic of four-stranded intercalated DNA. of stabilizing stacking interactions between the aromatic ring Indeed, the unusually strong nuclear overhauser effect signals systems of adjacent C-C+ base pairs from intercalated du- between inter-strand sugar Hi' protons and Hi' and H4' plexes.
    [Show full text]
  • Molecular Targets and Biological Functions of Camp Signaling in Arabidopsis
    biomolecules Article Molecular Targets and Biological Functions of cAMP Signaling in Arabidopsis Ruqiang Xu 1,2,*, Yanhui Guo 1, Song Peng 1, Jinrui Liu 1, Panyu Li 1, Wenjing Jia 1 and Junheng Zhao 1 1 School of Agricultural Sciences, Zhengzhou University, Zhengzhou 450001, China; [email protected] (Y.G.); [email protected] (S.P.); [email protected] (J.L.); [email protected] (P.L.); [email protected] (W.J.); [email protected] (J.Z.) 2 Zhengzhou Research Base, State Key Laboratory of Cotton Biology, Zhengzhou University, Zhengzhou 450001, China * Correspondence: [email protected]; Tel.: +86-0371-6778-5095 Abstract: Cyclic AMP (cAMP) is a pivotal signaling molecule existing in almost all living organisms. However, the mechanism of cAMP signaling in plants remains very poorly understood. Here, we employ the engineered activity of soluble adenylate cyclase to induce cellular cAMP elevation in Arabidopsis thaliana plants and identify 427 cAMP-responsive genes (CRGs) through RNA-seq analysis. Induction of cellular cAMP elevation inhibits seed germination, disturbs phytohormone contents, promotes leaf senescence, impairs ethylene response, and compromises salt stress tolerance and pathogen resistance. A set of 62 transcription factors are among the CRGs, supporting a prominent role of cAMP in transcriptional regulation. The CRGs are significantly overrepresented in the pathways of plant hormone signal transduction, MAPK signaling, and diterpenoid biosynthesis, but + they are also implicated in lipid, sugar, K , nitrate signaling, and beyond. Our results provide a basic framework of cAMP signaling for the community to explore. The regulatory roles of cAMP signaling Citation: Xu, R.; Guo, Y.; Peng, S.; in plant plasticity are discussed.
    [Show full text]
  • Deoxyguanosine Cytotoxicity by a Novel Inhibitor of Furine Nucleoside Phosphorylase, 8-Amino-9-Benzylguanine1
    [CANCER RESEARCH 46, 519-523, February 1986] Potentiation of 2'-Deoxyguanosine Cytotoxicity by a Novel Inhibitor of Furine Nucleoside Phosphorylase, 8-Amino-9-benzylguanine1 Donna S. Shewach,2 Ji-Wang Chern, Katherine E. Pillóte,Leroy B. Townsend, and Peter E. Daddona3 Departments of Internal Medicine [D.S.S., P.E.D.], Biological Chemistry [P.E.D.], and Medicinal Chemistry [J-W.C., K.E.P., L.B.T.], University ol Michigan, Ann Arbor, Michigan 48109 ABSTRACT to the ADA-deficient disease state (2). PNP is an essential enzyme of the purine salvage pathway, We have synthesized and evaluated a series of 9-substituted catalyzing the phosphorolysis of guanosine, inosine, and their analogues of 8-aminoguanine, a known inhibitor of human purine 2'-deoxyribonucleoside derivatives to the respective purine nucleoside phosphorylase (PNP) activity. The ability of these bases. To date, several inhibitors of PNP have been identified, agents to inhibit PNP has been investigated. All compounds were and most of these compounds resemble purine bases or nucleo found to act as competitive (with inosine) inhibitors of PNP, with sides. The most potent inhibitors exhibit apparent K¡values in K¡values ranging from 0.2 to 290 /¿M.Themost potent of these the range of 10~6to 10~7 M (9-12). Using partially purified human analogues, 8-amino-9-benzylguanine, exhibited a K, value that erythrocyte PNP, the diphosphate derivative of acyclovir dis was 4-fold lower than that determined for the parent base, 8- played K¡values of 5.1 x 10~7 to 8.7 x 10~9 M, depending on aminoguanine.
    [Show full text]
  • Chapter 23 Nucleic Acids
    7-9/99 Neuman Chapter 23 Chapter 23 Nucleic Acids from Organic Chemistry by Robert C. Neuman, Jr. Professor of Chemistry, emeritus University of California, Riverside [email protected] <http://web.chem.ucsb.edu/~neuman/orgchembyneuman/> Chapter Outline of the Book ************************************************************************************** I. Foundations 1. Organic Molecules and Chemical Bonding 2. Alkanes and Cycloalkanes 3. Haloalkanes, Alcohols, Ethers, and Amines 4. Stereochemistry 5. Organic Spectrometry II. Reactions, Mechanisms, Multiple Bonds 6. Organic Reactions *(Not yet Posted) 7. Reactions of Haloalkanes, Alcohols, and Amines. Nucleophilic Substitution 8. Alkenes and Alkynes 9. Formation of Alkenes and Alkynes. Elimination Reactions 10. Alkenes and Alkynes. Addition Reactions 11. Free Radical Addition and Substitution Reactions III. Conjugation, Electronic Effects, Carbonyl Groups 12. Conjugated and Aromatic Molecules 13. Carbonyl Compounds. Ketones, Aldehydes, and Carboxylic Acids 14. Substituent Effects 15. Carbonyl Compounds. Esters, Amides, and Related Molecules IV. Carbonyl and Pericyclic Reactions and Mechanisms 16. Carbonyl Compounds. Addition and Substitution Reactions 17. Oxidation and Reduction Reactions 18. Reactions of Enolate Ions and Enols 19. Cyclization and Pericyclic Reactions *(Not yet Posted) V. Bioorganic Compounds 20. Carbohydrates 21. Lipids 22. Peptides, Proteins, and α−Amino Acids 23. Nucleic Acids **************************************************************************************
    [Show full text]
  • 2'-Deoxyguanosine Toxicity for B and Mature T Lymphoid Cell Lines Is Mediated by Guanine Ribonucleotide Accumulation
    2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation. Y Sidi, B S Mitchell J Clin Invest. 1984;74(5):1640-1648. https://doi.org/10.1172/JCI111580. Research Article Inherited deficiency of the enzyme purine nucleoside phosphorylase (PNP) results in selective and severe T lymphocyte depletion which is mediated by its substrate, 2'-deoxyguanosine. This observation provides a rationale for the use of PNP inhibitors as selective T cell immunosuppressive agents. We have studied the relative effects of the PNP inhibitor 8- aminoguanosine on the metabolism and growth of lymphoid cell lines of T and B cell origin. We have found that 2'- deoxyguanosine toxicity for T lymphoblasts is markedly potentiated by 8-aminoguanosine and is mediated by the accumulation of deoxyguanosine triphosphate. In contrast, the growth of T4+ mature T cell lines and B lymphoblast cell lines is inhibited by somewhat higher concentrations of 2'-deoxyguanosine (ID50 20 and 18 microM, respectively) in the presence of 8-aminoguanosine without an increase in deoxyguanosine triphosphate levels. Cytotoxicity correlates instead with a three- to fivefold increase in guanosine triphosphate (GTP) levels after 24 h. Accumulation of GTP and growth inhibition also result from exposure to guanosine, but not to guanine at equimolar concentrations. B lymphoblasts which are deficient in the purine salvage enzyme hypoxanthine guanine phosphoribosyltransferase are completely resistant to 2'-deoxyguanosine or guanosine concentrations up to 800 microM and do not demonstrate an increase in GTP levels. Growth inhibition and GTP accumulation are prevented by hypoxanthine or adenine, but not by 2'-deoxycytidine.
    [Show full text]
  • Mechanisms Whereby Extracellular Adenosine 3',5'- Monophosphate Inhibits Phosphate Transport in Cultured Opossum Kidney Cells and in Rat Kidney
    Mechanisms whereby extracellular adenosine 3',5'- monophosphate inhibits phosphate transport in cultured opossum kidney cells and in rat kidney. Physiological implication. G Friedlander, … , C Coureau, C Amiel J Clin Invest. 1992;90(3):848-858. https://doi.org/10.1172/JCI115960. Research Article The mechanism of phosphaturia induced by cAMP infusion and the physiological role of extracellular cAMP in modulation of renal phosphate transport were examined. In cultured opossum kidney cells, extracellular cAMP (10-1,000 microM) inhibited Na-dependent phosphate uptake in a time- and concentration-dependent manner. The effect of cAMP was reproduced by ATP, AMP, and adenosine, and was blunted by phosphodiesterase inhibitors or by dipyridamole which inhibits adenosine uptake. [3H]cAMP was degraded extracellularly into AMP and adenosine, and radioactivity accumulated in the cells as labeled adenosine and, subsequently, as adenine nucleotides including cAMP. Radioactivity accumulation was decreased by dipyridamole and by inhibitors of phosphodiesterases and ecto-5'-nucleotidase, assessing the existence of stepwise hydrolysis of extracellular cAMP and intracellular processing of taken up adenosine. In vivo, dipyridamole abolished the phosphaturia induced by exogenous cAMP infusion in acutely parathyroidectomized (APTX) rats, decreased phosphate excretion in intact rats, and blunted phosphaturia induced by PTH infusion in APTX rats. These results indicate that luminal degradation of cAMP into adenosine, followed by cellular uptake of the nucleoside by tubular cells, is a key event which accounts for the phosphaturic effect of exogenous cAMP and for the part of the phosphaturic effect of PTH which is mediated by cAMP added to the tubular lumen under the influence of the hormone.
    [Show full text]
  • Inosine Binds to A3 Adenosine Receptors and Stimulates Mast Cell Degranulation
    Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. X Jin, … , B R Duling, J Linden J Clin Invest. 1997;100(11):2849-2857. https://doi.org/10.1172/JCI119833. Research Article We investigated the mechanism by which inosine, a metabolite of adenosine that accumulates to > 1 mM levels in ischemic tissues, triggers mast cell degranulation. Inosine was found to do the following: (a) compete for [125I]N6- aminobenzyladenosine binding to recombinant rat A3 adenosine receptors (A3AR) with an IC50 of 25+/-6 microM; (b) not bind to A1 or A2A ARs; (c) bind to newly identified A3ARs in guinea pig lung (IC50 = 15+/-4 microM); (d) lower cyclic AMP in HEK-293 cells expressing rat A3ARs (ED50 = 12+/-5 microM); (e) stimulate RBL-2H3 rat mast-like cell degranulation (ED50 = 2.3+/-0.9 microM); and (f) cause mast cell-dependent constriction of hamster cheek pouch arterioles that is attenuated by A3AR blockade. Inosine differs from adenosine in not activating A2AARs that dilate vascular smooth muscle and inhibit mast cell degranulation. The A3 selectivity of inosine may explain why it elicits a monophasic arteriolar constrictor response distinct from the multiphasic dilator/constrictor response to adenosine. Nucleoside accumulation and an increase in the ratio of inosine to adenosine may provide a physiologic stimulus for mast cell degranulation in ischemic or inflamed tissues. Find the latest version: https://jci.me/119833/pdf Inosine Binds to A3 Adenosine Receptors and Stimulates Mast Cell Degranulation Xiaowei Jin,* Rebecca K. Shepherd,‡ Brian R. Duling,‡ and Joel Linden‡§ *Department of Biochemistry, ‡Department of Molecular Physiology and Biological Physics, and §Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908 Abstract Mast cells are found in the lung where they release media- tors that constrict bronchiolar smooth muscle.
    [Show full text]
  • Adenosine Challenge Information for Patients Your Doctor Has Recommended That You Have an Adenosine Challenge
    Adenosine challenge Information for patients Your doctor has recommended that you have an adenosine challenge. The purpose of this test is to see if you have an accessory pathway called ‘Wolff-Parkinson-White (WPW) syndrome’. What is an accessory pathway? This is an extra electrical connection between the top chambers (atria) and bottom chambers (ventricles) of the heart. This extra electrical connection may allow electrical signals to bypass the normal route in your heart and form a short circuit. This can result in your heart beating abnormally fast for periods of time, which is called supra-ventricular tachycardia (SVT). This is not usually dangerous, but can cause unpleasant symptoms, such as a racing heart (palpitations), dizziness, chest pain, shortness of breath or, rarely, may cause you to collapse. Although the extra connection is present from birth (congenital), symptoms may not develop until later in life. In some cases, WPW syndrome may be life-threatening, particularly if it occurs alongside a type of irregular heartbeat called atrial fibrillation. However, this is rare and treatment can completely remove this risk. page 2 How is an accessory pathway diagnosed? Adenosine is the drug used in this test. It belongs to a group of medicines called anti-arrhythmics. Adenosine blocks electrical signals through the atrio-ventricular (AV) node. This means signals cannot travel from the top to the bottom chambers of the heart for a few seconds, until the drug effects wear off. If an accessory pathway (extra connection) is present, the electrical signals can still travel down to the ventricles, and this will show up on the ECG.
    [Show full text]
  • Lethality of Adenosine for Cultured Mammalian Cells by Interference with Pyrimidine Biosynthesis
    J. Cell Set. 13, 429-439 (i973) 429 Printed in Great Britain LETHALITY OF ADENOSINE FOR CULTURED MAMMALIAN CELLS BY INTERFERENCE WITH PYRIMIDINE BIOSYNTHESIS K. ISHII* AND H. GREEN Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139, U.S.A. SUMMARY Adenosine at low concentration is toxic to mammalian cells in culture. This may escape notice because some sera (such as calf or human) commonly used in culture media, contain adenosine deaminase. In the absence of serum deaminase, adenosine produced inhibition of growth of a number of established cell lines at concentrations as low as 5 x io~* M, and killed at 2 x io~5 M. This effect required the presence of cellular adenosine kinase, since a mutant line deficient in this enzyme was 70-fold less sensitive to adenosine. The toxic substance is therefore derived from adenosine by phosphorylation, and is probably one of the adenosine nucleotides. The toxic effect of adenosine in concentrations up to 2 x io~* M was completely prevented by the addition of uridine or of pyrimidines potentially convertible to uridine, suggesting that the adenosine was interfering with endogenous synthesis of uridylate. In the presence of adenosine, the conversion of labelled aspartate to uridine nucleotides was reduced by 80-85 %> and labelled orotate accumulated in both the cells and in the culture medium. The lethality of adenosine results from inhibition by one of its nucleotide products of the synthesis of uridylate at the stage of phosphoribosylation of orotate. INTRODUCTION Though adenosine is not an intermediate on the endogenous pathway of purine biosynthesis, it can be efficiently utilized through the purine salvage pathways as the sole purine source in cultured mammalian cells whose endogenous purine synthesis is blocked by aminopterin (Green & Ishii, 1972).
    [Show full text]
  • Bioenergetics, ATP & Enzymes
    Bioenergetics, ATP & Enzymes Some Important Compounds Involved in Energy Transfer and Metabolism Bioenergetics can be defined as all the energy transfer mechanisms occurring within living organisms. Energy transfer is necessary because energy cannot be created and it cannot be destroyed (1st law of thermodynamics). Organisms can acquire energy from chemicals (chemotrophs) or they can acquire it from light (phototrophs), but they cannot make it. Thermal energy (heat) from the environment can influence the rate of chemical reactions, but is not generally considered an energy source organisms can “capture” and put to specific uses. Metabolism, all the chemical reactions occurring within living organisms, is linked to bioenergetics because catabolic reactions release energy (are exergonic) and anabolic reactions require energy (are endergonic). Various types of high-energy compounds can “donate” the energy required to drive endergonic reactions, but the most commonly used energy source within cells is adenosine triphosphate (ATP), a type of coenzyme. When this molecule is catabolized (broken down), the energy released can be used to drive a wide variety of synthesis reactions. Endergonic reactions required for the synthesis of nucleic acids (DNA and RNA) are exceptions because all the nucleotides incorporated into these molecules are initially high-energy molecules as described below. The nitrogenous base here is adenine, the sugar is the pentose monosaccharide ribose and there are three phosphate groups attached. The sugar and the base form a molecule called a nucleoside, and the number of phosphate groups bound to the nucleoside is variable; thus alternative forms of this molecule occur as adenosine monophosphate (AMP) and adenosine diphosphate (ADP).
    [Show full text]
  • Inosine in Biology and Disease
    G C A T T A C G G C A T genes Review Inosine in Biology and Disease Sundaramoorthy Srinivasan 1, Adrian Gabriel Torres 1 and Lluís Ribas de Pouplana 1,2,* 1 Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, 08028 Barcelona, Catalonia, Spain; [email protected] (S.S.); [email protected] (A.G.T.) 2 Catalan Institution for Research and Advanced Studies, 08010 Barcelona, Catalonia, Spain * Correspondence: [email protected]; Tel.: +34-934034868; Fax: +34-934034870 Abstract: The nucleoside inosine plays an important role in purine biosynthesis, gene translation, and modulation of the fate of RNAs. The editing of adenosine to inosine is a widespread post- transcriptional modification in transfer RNAs (tRNAs) and messenger RNAs (mRNAs). At the wobble position of tRNA anticodons, inosine profoundly modifies codon recognition, while in mRNA, inosines can modify the sequence of the translated polypeptide or modulate the stability, localization, and splicing of transcripts. Inosine is also found in non-coding and exogenous RNAs, where it plays key structural and functional roles. In addition, molecular inosine is an important secondary metabolite in purine metabolism that also acts as a molecular messenger in cell signaling pathways. Here, we review the functional roles of inosine in biology and their connections to human health. Keywords: inosine; deamination; adenosine deaminase acting on RNAs; RNA modification; translation Citation: Srinivasan, S.; Torres, A.G.; Ribas de Pouplana, L. Inosine in 1. Introduction Biology and Disease. Genes 2021, 12, 600. https://doi.org/10.3390/ Inosine was one of the first nucleobase modifications discovered in nucleic acids, genes12040600 having been identified in 1965 as a component of the first sequenced transfer RNA (tRNA), tRNAAla [1].
    [Show full text]